Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease

Clinical trial NCT00239564 · COMPLETED

Trial details

NCT number: NCT00239564
Sponsor: Impax Laboratories, LLC
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Idiopathic Parkinson's Disease

Start date: 2005-10-01
Primary completion: 2007-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.